RVL Pharmaceuticals PLC (RVLPQ)
0.00
USD |
OTCM |
May 16, 16:00
RVL Pharmaceuticals Accounts Payable (Quarterly): 2.53M for June 30, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 2.53M |
| March 31, 2023 | 2.63M |
| December 31, 2022 | 2.407M |
| September 30, 2022 | 7.003M |
| June 30, 2022 | 5.437M |
| March 31, 2022 | 4.732M |
| December 31, 2021 | 3.777M |
| September 30, 2021 | 4.449M |
| June 30, 2021 | 1.549M |
| March 31, 2021 | 4.522M |
| December 31, 2020 | 3.128M |
| Date | Value |
|---|---|
| September 30, 2020 | 7.909M |
| June 30, 2020 | 8.798M |
| March 31, 2020 | 8.784M |
| December 31, 2019 | 8.495M |
| September 30, 2019 | 9.905M |
| June 30, 2019 | 18.92M |
| March 31, 2019 | 20.59M |
| December 31, 2018 | 24.87M |
| September 30, 2018 | 27.86M |
| June 30, 2018 | 32.56M |
| December 31, 2017 | 36.07M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.549M
Minimum
Jun 2021
18.92M
Maximum
Jun 2019
6.175M
Average
4.732M
Median
Mar 2022
Accounts Payable (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.117M |
| Palatin Technologies Inc | 3.443M |
| iBio Inc | 1.859M |
| Theriva Biologics Inc | 0.571M |
| Oragenics Inc | 1.245M |